Stock Updates

Today’s Top Gainers in the Market Boston Scientific Corporation (NYSE:BSX) from Healthcare

Today’s top gainers include the company Boston Scientific Corporation (NYSE:BSX) which is in the industry Medical Appliances & Equipment, gaining -0.54% today. In the last week its performance is 1.44%, and 21.05% for the past quarter. Currently, Boston Scientific Corporation, BSX has a target price of 24.89, so today’s gain of -0.54% is a significant step towards its target price. The GAP today is therefore 0.00%.

Boston Scientific Corporation (NYSE:BSX), has a market cap of 32456.33, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 95.50%.

At the current price of 23.79, it has a dividend yield of *TBA, and its target price is 24.89. This is with a profit margin of -0.50%, and total debt/equity of 0.88. Boston Scientific Corporation (NYSE:BSX) has a P/E of *TBA, as well as a forward P/E of 19.38.

With a current EPS of -0.03, and a forecasted EPS growth for next year at 13.00%,Boston Scientific Corporation (NYSE:BSX) has had a EPS growth for the past five years at 24.00%. For the next five years EPS growth is projected to be 12.70%.

Performance for the year is 35.83%. Since its IPO date on 5/19/1992, the total performance to date is 29.72%.

Volume today for Boston Scientific Corporation (NYSE:BSX), is 1990123, while its average volume is 11650.85. Whilst the total gain today was -0.54%, it did have a day high of -2.70%.

Volatility for this week has been at 1.69%, and 1.52% for the month. The 52-week low for Boston Scientific Corporation, BSX has been 67.77%, while the 52-week-high has reached -2.70%.

Looking at its return of investments, which is 0.70%, and its return on assets is -0.20%. Boston Scientific Corporation (NYSE:BSX) has an operating margin of -0.80%. With a sales growth of 11.10% quarter over quarter. Bearing in mind that Boston Scientific Corporation, BSX is in the sector Healthcare, its long-term debt/equity is 0.84, and has a current ratio of 1.2 and 0.8 for quick ratio.

So what is the value of Boston Scientific Corporation? Well its PEG is *TBA, and the P/S is 4.23, along with a P/B of 5. Meanwhile it has a p/cash of 96.02.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment